Farmako, the Frankfurt-based company for specialised pharmaceutical wholesale, confirms the existence of the necessary marketing authorisations in accordance with the Ordinance on Medicinal Products Treated with Radioactive or Ionising Radiation (AMRadV).
Farmako GmbH is one of the few pharmaceutical wholesalers to hold the approval granted by the Federal Institute for Drugs and Medical Devices (BfArM) for the medicinal cannabis flowers currently available on the German market that have been treated with ionising radiation. This special approval is mandatory for the marketing of radiation-treated medicinal products.
Farmako continues to prove itself as a reliable pharmaceutical wholesaler, ensuring a sustainable supply of cannabis medicines to patients.
Cannabis flowers as herbal medicinal products are often treated with ionising radiation (e.g. gamma rays) by specialised, licensed irradiation companies in order to free them from potentially harmful germ contamination (sterilisation) and thus counteract possible health risks in the context of treating patients with cannabis flowers. Such radiation sterilization or decontamination is also used in other areas of drug production, e.g. antibiotics or sterile medical devices. According to available studies, radiation sterilization does not cause significant changes in the composition of medical cannabis and is thus a recognized method of decontamination.
Farmako GmbH is a pharmaceutical wholesaler based in Frankfurt. The company focuses on the distribution of medicinal cannabis to pharmacies with the aim of catching up with the backlog in the supply of cannabis medicines to patients. Farmako plans to expand its business model to other European countries with the appropriate legal basis to become Europe's leading wholesaler of medical cannabis. The company has already been operating the distribution of cannabis products in Germany since March 2019 and has the necessary distribution licenses in the UK to start active sales there in 2020. Farmako is a 100% subsidiary of AgraFlora Organics International Inc.
More information at: www.farmako.de
AgraFlora Organics International Inc. is a growth-oriented and diversified company focused on the international cannabis industry. AgraFlora operates primarily in Canada, the world's leading market for regulated and liberalized cannabis. The AgraFlora group includes: Edibles & Infusions, a fully automated cannabis edibles production facility in Winnipeg, MB; Propagation Services Canada, one of the largest cannabis greenhouse facilities focused on cost-optimized cannabis cultivation in Delta, BC; AAA Heidelberg, an indoor boutique cannabis production facility in London, ON. AgraFlora's wholly owned subsidiary Farmako GmbH, based in Frankfurt, Germany, aims to become Europe's leading distributor of medical cannabis.
More information at: https://agraflora.com
Press contact: firstname.lastname@example.org